Suppr超能文献

烷基胺对肥大细胞肽能途径的抑制机制。

The mechanism of inhibition of alkylamines on the mast-cell peptidergic pathway.

作者信息

Fischer T, Bronner C, Landry Y, Mousli M

机构信息

Laboratoire de Neuroimmunopharmacologie, Université Louis Pasteur-Strasbourg I, Illkirch, France.

出版信息

Biochim Biophys Acta. 1993 Apr 16;1176(3):305-12. doi: 10.1016/0167-4889(93)90059-x.

Abstract

GTP-binding proteins are known to play an important role in controlling mast-cell exocytosis and are described as the primary targets of peptidic mast-cell histamine releasers. The mechanism of inhibition of the mast-cell peptidergic pathway by alkylamines, which are selective inhibitors of this pathway, was investigated using intact or permeabilized rat peritoneal mast cells. Histamine release induced by GTP gamma S and by mastoparan (a venom peptide activating G proteins) was inhibited by pretreating mast cells with 0.1 to 3 micrograms/ml of a mixture of benzalkonium chloride containing in majority a twelve-carbon-atom aliphatic chain (BAC(C approximately 12)). Pure benzalkonium chloride, with a fourteen-carbon-atom aliphatic chain (BAC (C14)), at 5 to 10 microM also inhibited histamine release induced by GTP gamma S and mastoparan. The dose-response curve of mastoparan-induced histamine release from intact mast cells was shifted to the right by various concentrations of BAC (C14). Similar results were obtained with another alkylamine differing from BAC (C14) by the absence of the benzene ring, tetradecyltrimethylammonium bromide, TAB (C14). This illustrates that the presence of the phenyl radical is not required for the inhibitory effect of benzalkonium chloride. BAC (C approximately 12) and BAC (C14) inhibited the generation of inositol polyphosphates induced by GTP gamma S. BAC (C approximately 12) and TAB (C14) inhibited the mastoparan-stimulated GTPase activity from mast-cell Gi-like proteins. These results suggest that alkylamines exert selectively their inhibitory effect via an interaction with mast-cell Gi-like proteins coupled to phospholipase C, i.e., at an early stage in the stimulus-secretion coupling process.

摘要

已知GTP结合蛋白在控制肥大细胞胞吐作用中发挥重要作用,并且被描述为肽类肥大细胞组胺释放剂的主要靶点。使用完整的或通透的大鼠腹膜肥大细胞,研究了作为该途径选择性抑制剂的烷基胺对肥大细胞肽能途径的抑制机制。用0.1至3微克/毫升主要含有十二碳原子脂肪链的苯扎氯铵混合物(BAC(C约12))预处理肥大细胞,可抑制由GTPγS和mastoparan(一种激活G蛋白的毒液肽)诱导的组胺释放。含有十四碳原子脂肪链的纯苯扎氯铵(BAC(C14)),浓度为5至10微摩尔时,也抑制由GTPγS和mastoparan诱导的组胺释放。不同浓度的BAC(C14)使完整肥大细胞中mastoparan诱导的组胺释放的剂量反应曲线右移。对于另一种与BAC(C14)不同、没有苯环的烷基胺十四烷基三甲基溴化铵(TAB(C14)),也获得了类似结果。这表明苯扎氯铵的抑制作用并不需要苯基的存在。BAC(C约12)和BAC(C14)抑制由GTPγS诱导的肌醇多磷酸的生成。BAC(C约12)和TAB(C14)抑制肥大细胞类Gi蛋白的mastoparan刺激的GTP酶活性。这些结果表明,烷基胺通过与偶联磷脂酶C的肥大细胞类Gi蛋白相互作用,即在刺激-分泌偶联过程的早期阶段,选择性地发挥其抑制作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验